First-in-human Trial of Home Brain Pressure Measured Using Kitea ICP Sensor, Placed During Hydrocephalus Shunt Surgery.
Key facts
- Who runs it
- University of Auckland, New Zealand
- Where
- New Zealand1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 21 people enrolled
- Started
- 27 May 2024
- Ended
- Apr 2026
- Type of study
- Interventional
- Treatments tested
- Kitea ICP Sensor
- Record updated
- 13 February 2026
Who can take part
- Age
- 1 year and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Participants with a condition requiring cerebral spinal fluid shunting who are undergoing initial shunt placement or shunt revision surgery
- Adults: Age > 16 years; Children: Age >1 and <15
Who cannot take part
- Other active implanted medical devices e.g. pacemaker, cochlear implant, implantable cardioverter defibrillator, deep brain stimulation devices
- Paediatric: Failure to obtain assent in a cognitively competent child along with parental consent or parent unable to consent
- Neurologic or other condition that would prevent compliance with protocol
- Terminal illness with expected survival < 1 year
- Underlying medical condition that would make the participant more prone to surgical infections
- Participants with conditions likely to require radiation therapy
- Adults: Unable to give informed consent
- Cortical mantle < 20 mm
- Unable to participate in follow-up for 3 months (e.g., travelling overseas for an extended period)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Patients with hydrocephalus have an abnormal build-up of fluid around the brain and need a tube surgically implanted to drain that fluid. Patients and their caregivers live with the constant fear that the tube will block. Warning symptoms include irritability, headaches and vomiting. Unfortunately, there is no way of telling when fluid build-up is causing a rise in brain pressure and potentially impeding blood flow to the brain (life threatening) except for a brain scan in hospital and possibly hospitalisation.
Read full original descriptionShow less
The investigators want to improve the lives of patients with hydrocephalus. They have developed a tool for parents and caregivers to monitor the pressure in the brain remotely via a sensor placed alongside the drainage tube. The device has been shown to be safe and to give reliable brain pressure readings using a large animal model (sheep). This study is a first-in-human safety study to show it is safe for patient use.
The group in the trial
- Kitea ICP SensorTreatment being tested
At the same time as this surgery, the Kitea Sensor will be placed in the brain near the shunt. Participants will be asked to make measurements of their brain pressure at home using the Kitea ICP System for the next 3 months. Aside from the placement of the Kitea Sensor and home measurements of ICP using the Kitea ICP system, all clinical interventions will be standard of care.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Wireless HOME Monitoring of Intracranial (BRAIN) PRESSURE
- Record updated
- 13 February 2026